Isomorphic Labs announced strategic collaborations with leading pharmaceutical companies, Eli Lilly and Company and Novartis. These partnerships have the potential to be...

Bayer and RTW Investments have announced an equity investment in Jixing Pharmaceuticals of €32 million ($35 million) and €116 million ($127 million) respectively.

Gilead has exclusive rights for the advancement and commercialization of anti-IL18 binding protein antibodies targeting various tumor types. Gilead commits to a...

Berlin Mayor Kai Wegner and Bayer's Stefan Oelrich unveil a high-tech facility as part of a global billion-euro investment initiative. The advanced space, featuring a...

Merck & Co. (MSD) and Caraway Therapeutics announced that the companies have agreed Merck & Co., through a subsidiary, will acquire Caraway Therapeutics for a total...

Quotient Sciences, a drug development and manufacturing accelerator, has invested significantly in expanding its sterile fill/finish capabilities at its Alnwick, UK...

The 7th edition of the CPHI Annual Survey was unveiled today highlighting trends for 2024. A total of 250 pharmaceutical executives were surveyed with 35 probing...

European NGOs have welcomed the EU’s plans for an overhaul of pharmaceutical legislation – the first in two decades – presented this week in Brussels. The drugs industry...